| Nature s second pandemic progress report #MMPMID33087916äNature 2020[Oct]; 586 (7830): 473-474 PMID33087916show ga
ä|Antibodies, Monoclonal/immunology/therapeutic use[MESH]|Antibodies, Neutralizing/immunology/therapeutic use[MESH]|COVID-19[MESH]|COVID-19 Vaccines[MESH]|Coronavirus Infections/epidemiology/*immunology/prevention & control[MESH]|Dexamethasone/pharmacology/therapeutic use[MESH]|Drug Approval[MESH]|Humans[MESH]|Pandemics/prevention & control[MESH]|Pneumonia, Viral/epidemiology/*immunology/prevention & control[MESH]|T-Lymphocytes/immunology[MESH]|Time Factors[MESH]|Viral Vaccines/adverse effects/*immunology/standards[MESH]
DeepDyve Pubget Overpricing |
|